Quantifying HIV-1 transmission due to contaminated injections.
Assessments of the importance of different routes of HIV-1 (HIV) transmission are vital for prioritization of control efforts. Lack of consistent direct data and large uncertainty in the risk of HIV transmission from HIV-contaminated injections has made quantifying the proportion of transmission cau...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2007
|
| _version_ | 1797099905958805504 |
|---|---|
| author | White, R Ben, S Kedhar, A Orroth, K Biraro, S Baggaley, R Whitworth, J Korenromp, E Ghani, A Boily, M Hayes, R |
| author_facet | White, R Ben, S Kedhar, A Orroth, K Biraro, S Baggaley, R Whitworth, J Korenromp, E Ghani, A Boily, M Hayes, R |
| author_sort | White, R |
| collection | OXFORD |
| description | Assessments of the importance of different routes of HIV-1 (HIV) transmission are vital for prioritization of control efforts. Lack of consistent direct data and large uncertainty in the risk of HIV transmission from HIV-contaminated injections has made quantifying the proportion of transmission caused by contaminated injections in sub-Saharan Africa difficult and unavoidably subjective. Depending on the risk assumed, estimates have ranged from 2.5% to 30% or more. We present a method based on an age-structured transmission model that allows the relative contribution of HIV-contaminated injections, and other routes of HIV transmission, to be robustly estimated, both fully quantifying and substantially reducing the associated uncertainty. To do this, we adopt a Bayesian perspective, and show how prior beliefs regarding the safety of injections and the proportion of HIV incidence due to contaminated injections should, in many cases, be substantially modified in light of age-stratified incidence and injection data, resulting in improved (posterior) estimates. Applying the method to data from rural southwest Uganda, we show that the highest estimates of the proportion of incidence due to injections are reduced from 15.5% (95% credible interval) (0.7%, 44.9%) to 5.2% (0.5%, 17.0%) if random mixing is assumed, and from 14.6% (0.7%, 42.5%) to 11.8% (1.2%, 32.5%) under assortative mixing. Lower, and more widely accepted, estimates remain largely unchanged, between 1% and 3% (0.1-6.3%). Although important uncertainty remains, our analysis shows that in rural Uganda, contaminated injections are unlikely to account for a large proportion of HIV incidence. This result is likely to be generalizable to many other populations in sub-Saharan Africa. |
| first_indexed | 2024-03-07T05:30:11Z |
| format | Journal article |
| id | oxford-uuid:e1fbd64d-8a6a-4bf0-8c1e-31e90bb375e2 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:30:11Z |
| publishDate | 2007 |
| record_format | dspace |
| spelling | oxford-uuid:e1fbd64d-8a6a-4bf0-8c1e-31e90bb375e22022-03-27T09:57:58ZQuantifying HIV-1 transmission due to contaminated injections.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e1fbd64d-8a6a-4bf0-8c1e-31e90bb375e2EnglishSymplectic Elements at Oxford2007White, RBen, SKedhar, AOrroth, KBiraro, SBaggaley, RWhitworth, JKorenromp, EGhani, ABoily, MHayes, RAssessments of the importance of different routes of HIV-1 (HIV) transmission are vital for prioritization of control efforts. Lack of consistent direct data and large uncertainty in the risk of HIV transmission from HIV-contaminated injections has made quantifying the proportion of transmission caused by contaminated injections in sub-Saharan Africa difficult and unavoidably subjective. Depending on the risk assumed, estimates have ranged from 2.5% to 30% or more. We present a method based on an age-structured transmission model that allows the relative contribution of HIV-contaminated injections, and other routes of HIV transmission, to be robustly estimated, both fully quantifying and substantially reducing the associated uncertainty. To do this, we adopt a Bayesian perspective, and show how prior beliefs regarding the safety of injections and the proportion of HIV incidence due to contaminated injections should, in many cases, be substantially modified in light of age-stratified incidence and injection data, resulting in improved (posterior) estimates. Applying the method to data from rural southwest Uganda, we show that the highest estimates of the proportion of incidence due to injections are reduced from 15.5% (95% credible interval) (0.7%, 44.9%) to 5.2% (0.5%, 17.0%) if random mixing is assumed, and from 14.6% (0.7%, 42.5%) to 11.8% (1.2%, 32.5%) under assortative mixing. Lower, and more widely accepted, estimates remain largely unchanged, between 1% and 3% (0.1-6.3%). Although important uncertainty remains, our analysis shows that in rural Uganda, contaminated injections are unlikely to account for a large proportion of HIV incidence. This result is likely to be generalizable to many other populations in sub-Saharan Africa. |
| spellingShingle | White, R Ben, S Kedhar, A Orroth, K Biraro, S Baggaley, R Whitworth, J Korenromp, E Ghani, A Boily, M Hayes, R Quantifying HIV-1 transmission due to contaminated injections. |
| title | Quantifying HIV-1 transmission due to contaminated injections. |
| title_full | Quantifying HIV-1 transmission due to contaminated injections. |
| title_fullStr | Quantifying HIV-1 transmission due to contaminated injections. |
| title_full_unstemmed | Quantifying HIV-1 transmission due to contaminated injections. |
| title_short | Quantifying HIV-1 transmission due to contaminated injections. |
| title_sort | quantifying hiv 1 transmission due to contaminated injections |
| work_keys_str_mv | AT whiter quantifyinghiv1transmissionduetocontaminatedinjections AT bens quantifyinghiv1transmissionduetocontaminatedinjections AT kedhara quantifyinghiv1transmissionduetocontaminatedinjections AT orrothk quantifyinghiv1transmissionduetocontaminatedinjections AT biraros quantifyinghiv1transmissionduetocontaminatedinjections AT baggaleyr quantifyinghiv1transmissionduetocontaminatedinjections AT whitworthj quantifyinghiv1transmissionduetocontaminatedinjections AT korenrompe quantifyinghiv1transmissionduetocontaminatedinjections AT ghania quantifyinghiv1transmissionduetocontaminatedinjections AT boilym quantifyinghiv1transmissionduetocontaminatedinjections AT hayesr quantifyinghiv1transmissionduetocontaminatedinjections |